203 related articles for article (PubMed ID: 23140120)
21. Immunotherapy for advanced melanoma: fulfilling the promise.
Gogas H; Polyzos A; Kirkwood J
Cancer Treat Rev; 2013 Dec; 39(8):879-85. PubMed ID: 23725878
[TBL] [Abstract][Full Text] [Related]
22. Signaling and Immune Regulation in Melanoma Development and Responses to Therapy.
Lin WM; Fisher DE
Annu Rev Pathol; 2017 Jan; 12():75-102. PubMed ID: 27959628
[TBL] [Abstract][Full Text] [Related]
23. The tumour immune landscape and its implications in cutaneous melanoma.
Attrill GH; Ferguson PM; Palendira U; Long GV; Wilmott JS; Scolyer RA
Pigment Cell Melanoma Res; 2021 May; 34(3):529-549. PubMed ID: 32939993
[TBL] [Abstract][Full Text] [Related]
24. Melanoma immunotherapy: historical precedents, recent successes and future prospects.
Raaijmakers MI; Rozati S; Goldinger SM; Widmer DS; Dummer R; Levesque MP
Immunotherapy; 2013 Feb; 5(2):169-82. PubMed ID: 23413908
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy in melanoma: Recent advances and future directions.
Franklin C; Livingstone E; Roesch A; Schilling B; Schadendorf D
Eur J Surg Oncol; 2017 Mar; 43(3):604-611. PubMed ID: 27769635
[TBL] [Abstract][Full Text] [Related]
26. Novel Targets in Melanoma: Intralesional and Combination Therapy to Manipulate the Immune Response.
Gingrich AA; Kirane AR
Surg Oncol Clin N Am; 2020 Jul; 29(3):467-483. PubMed ID: 32482321
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of melanoma: targeting defined antigens.
Cebon J; MacGregor D; Scott A; DeBoer R
Australas J Dermatol; 1997 Jun; 38 Suppl 1():S66-72. PubMed ID: 10994477
[TBL] [Abstract][Full Text] [Related]
28. T cell receptor therapy against melanoma-Immunotherapy for the future?
Winge-Main AK; Wälchli S; Inderberg EM
Scand J Immunol; 2020 Oct; 92(4):e12927. PubMed ID: 32640053
[TBL] [Abstract][Full Text] [Related]
29. Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma.
Eftimie R; Bramson JL; Earn DJ
J Theor Biol; 2010 Aug; 265(3):467-80. PubMed ID: 20450922
[TBL] [Abstract][Full Text] [Related]
30. Normalization Cancer Immunotherapy for Melanoma.
Vesely MD; Chen L
J Invest Dermatol; 2020 Jun; 140(6):1134-1142. PubMed ID: 32092349
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.
Komatsubara KM; Carvajal RD
Curr Oncol Rep; 2017 Jul; 19(7):45. PubMed ID: 28508938
[TBL] [Abstract][Full Text] [Related]
32. Myeloid-derived suppressor cells in malignant melanoma.
Umansky V; Sevko A; Gebhardt C; Utikal J
J Dtsch Dermatol Ges; 2014 Nov; 12(11):1021-7. PubMed ID: 25263083
[TBL] [Abstract][Full Text] [Related]
33. IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses.
Qu Q; Zhai Z; Xu J; Li S; Chen C; Lu B
Front Immunol; 2020; 11():634. PubMed ID: 32351508
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of immunotherapy in the treatment of melanoma.
Faries MB
Surg Oncol Clin N Am; 2006 Apr; 15(2):399-418. PubMed ID: 16632223
[TBL] [Abstract][Full Text] [Related]
35. [A malignus melanoma immunterápiájának lehetoségei].
Ladányi A
Magy Onkol; 2003; 47(1):113-7. PubMed ID: 12704464
[TBL] [Abstract][Full Text] [Related]
36. [Immunotherapy of malignant melanoma--basic principles and novel therapeutic approaches].
Enk AH; Becker JC; Schuler G
J Dtsch Dermatol Ges; 2006 Aug; 4(8):635-45. PubMed ID: 16895565
[TBL] [Abstract][Full Text] [Related]
37. Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition.
Lau PK; Ascierto PA; McArthur G
Curr Opin Immunol; 2016 Apr; 39():30-8. PubMed ID: 26765776
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cells in the immunotherapy of melanoma.
Ouyang Z; Wu H; Li L; Luo Y; Li X; Huang G
Tumour Biol; 2016 Jan; 37(1):77-85. PubMed ID: 26515336
[TBL] [Abstract][Full Text] [Related]
39. Re-inventing intratumoral immunotherapy for melanoma.
Triozzi PL; Tuthill RJ; Borden E
Immunotherapy; 2011 May; 3(5):653-71. PubMed ID: 21554094
[TBL] [Abstract][Full Text] [Related]
40. A new era in the treatment of melanoma: from biology to clinical practice.
Márquez-Rodas I; Martín Algarra S; Avilés Izquierdo JA; Custodio Cabello S; Martín M
Clin Transl Oncol; 2011 Nov; 13(11):787-92. PubMed ID: 22082642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
